There remains an ‘off-tumor and on-target’ limitation of targeting CS1 on hematopoietic cells: the potential for inducing a state of prolonged immunodeficiency due to high CS1 expression on CD8 T, NK, and probably also invariant NKT cells (iNKT) that may be clinically consequential. Here, SLAMF7 is linked to immunodeficiency disease.